NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.
Filter By:
Letter to Congressional Committee Leadership on Parity & Crisis Services
04/04/2022
Letter to House Energy & Commerce Committee leadership, expressing support for H.R. 7254, the Mental Health Justice and Parity Act of 2022, which would help expand crisis service behavioral health providers and close a gap in health insurance coverage for MH/SUD treatment for frontline workers.
Letter to Congressional Committee Leadership on Research & Innovation
04/04/2022
Letter to Senate HELP and House Energy & Commerce Committees leadership, expressing support for the Anna Westin Legacy Act of 2022 (S.3686/H.R.7249), which will reauthorize and expand the Substance Abuse and Mental Health Services Administration’s Center of Excellence for Eating Disorders.
Letter to House Bill Sponsors on Child & Adolescent Mental Health
04/04/2022
Letter to Representatives Schrier and Miller-Meeks, expressing support for the introduction of H.R. 7076, the Supporting Children’s Mental Health Care Access Act of 2022, which would reauthorize the Pediatric Mental Health Care Access Program at the Health Resources and Services Administration for five years and make program improvements.
Letter to Senate Bill Sponsors on Child & Adolescent Mental Health
04/04/2022
Letter to Senators Murphy and Cassidy, expressing support for the introduction of S. 3864, the Supporting Children’s Mental Health Care Access Act of 2022, which would reauthorize the Pediatric Mental Health Care Access Program at the Health Resources and Services Administration for five years and make program improvements.
Letter to Congressional Bill Sponsors on Medicare
04/02/2022
Letter to Congressional bill sponsors in support of H.R. 3173/S. 3018, The Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage.
Letter to Congressional Committee Leadership on Medication Access
03/31/2022
Letter to Senate Finance Committee Chairman Wyden and Ranking Member Crapo, urging the Committee to include the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act (S. 586) in the mental health legislative package currently under development.